Home Business of Cannabis North America

Matt Skynner, braingrid

byBofC

June 27, 2018

in Business of Cannabis North America, Meet the Industry, Newsfeed, Videos

Share on Facebook Share on Twitter

⏰ Pre-order discount ends Jan 15

-- Days

-- Hours

-- Mins

Data packs delivered January 2026

🔬 New Report Due January 2026

Global Medical Cannabis Market Review 2026

A comprehensive analysis of the international medical cannabis supply chain — examining country-specific data on exports, imports, market size, domestic production, and distribution landscapes. Understand the driving forces behind global supply dynamics, the impact of telemedicine on patient access, and regulatory changes shaping the market.

What's covered

📊 Global supply chain overview — understand export/import dynamics and domestic production capabilities
🌍 8 export country snapshots — Canada, Portugal, Denmark, North Macedonia, Spain, Australia, Czech Republic, South Africa
👥 6 patient market snapshots — Australia, Germany, UK, Poland, Brazil, France
🔮 Key themes — Canada's global impact, telemedicine growth, new market openings, quota changes

Export Markets

🇨🇦 Canada 🇵🇹 Portugal 🇩🇰 Denmark 🇲🇰 N. Macedonia 🇪🇸 Spain 🇦🇺 Australia 🇨🇿 Czechia 🇿🇦 South Africa

Patient Markets

🇦🇺 Australia 🇩🇪 Germany 🇬🇧 UK 🇵🇱 Poland 🇧🇷 Brazil 🇫🇷 France

100% free • No credit card required

Premium Data Packs

Save 15%

Medical Market Sizing – Key International Markets £2,049£1,742

Market sizing & patient forecasts for 14 markets (2026–2030). Includes scenario forecasting for Australia & Germany.

UK & Germany Distributor Portfolios £1,625£1,381

Evolution of distributor product portfolios by product count.

UK & Germany Product & Pricing £1,869£1,589

Monthly pricing development, average pricing by month and product format.

Export/Import Comparison £1,265£1,075

Key market import/export volumes with export and import market comparisons.

Price Evolution – UK & Germany £1,329£1,130

Average price evolution comparison between UK and Germany markets.

Pre-order data packs → Data packs delivered digitally in January 2026. Pre-order pricing available until January 15.

As trusted by

DIAGEO KPMG Coca-Cola BARCLAYS BNP PARIBAS AB InBev NOVARTIS Johnson & Johnson PEPSICO AXA POLITICO Bloomberg amazon CNN Business

Part of our annual market review series GDPR compliant

Tags: agtech braingrid innovation technology

Daniel Sax, Sensi Properties

BofC

Trump considers using executive order to reschedule cannabis

Business of Cannabis North America

Republican Lawmakers Openly Defy Trump on Cannabis Rescheduling

by Ben Stevens

January 13, 2026

As the excitement around President Donald Trump's executive order to push forward with cannabis rescheduling has faded, the bill is...

Cannabis Rescheduling: The industry weighs in

Business of Cannabis North America

Industry Leaders React to Historic Cannabis Rescheduling

by Business of Cannabis

December 19, 2025

President Donald Trump's executive order directing federal agencies to move cannabis from Schedule I to Schedule III of the Controlled...

President Donald Trump signs executive order to reschedule cannabis

Cannabis Rescheduling is Here: Trump Signs Executive Order to Move Cannabis to Schedule III

December 19, 2025

CONNECT

Industry Leaders React to Historic Cannabis Rescheduling

by Business of Cannabis

December 23, 2025

President Donald Trump's executive order directing federal agencies to move cannabis from Schedule I to Schedule III of the Controlled...

Cannabis Rescheduling is Here: Trump Signs Executive Order to Move Cannabis to Schedule III

by Ben Stevens

December 23, 2025

After two years of speculation, rumours, stock swings, broken promises, and political theatre, President Donald Trump officially signed an executive...

Could Trump Actually Reschedule Cannabis This Time?

by Ben Stevens

December 23, 2025

Cannabis Rescheduling fervour has once again reached dramatic levels following media reports that President Donald Trump is considering pushing through...